Sitemap
Blog
- 08/10/2020 - Microbiome: Zero to One
- 08/03/2020 - CHO cell line. A 60-year-old story.
- 07/17/2020 - Cancer & Bacteria, a long story rising from the ashes
- 07/01/2020 - IL1RAP, a new biomarker of interest for cancer targeting
- 06/26/2020 - An introduction to the Exosome world
- 06/23/2020 - Revealing the full potential of Adeno Associated Virus thanks to molecular biology
- 06/09/2020 - How much do you know about COVID-19 proteins?
- 06/02/2020 - Immediate Discount on SYnAbs COVID-19 products
- 05/25/2020 - Patients’ Immune Battle Against COVID-19
- 05/05/2020 - Latest News on COVID-19
- 04/03/2020 - Immune Response to Coronavirus infection
- 03/31/2020 - 11 Strategies To Treat Coronavirus You Should Know
- 03/17/2020 - Bispecific Antibody: The Janus God Of Therapeutics?
- 03/02/2020 - Top Facts You Don't Know About Rat Monoclonals
- 02/25/2020 - The Future Of Therapeutic Antibodies Development
- 02/19/2020 - More human than human is our motto
- 02/14/2020 - "Anta", "Block", "Neutra"...but Who Are They?
- 02/10/2020 - In Gut We Trust
- 02/04/2020 - Not One Monoclonal But Two mAbs can detect ANY PROTEIN!
- 01/30/2020 - The Dark Side Of CAR-T Therapy
- 01/16/2020 - In accordance with FDA, can a biotinylated mAb be replaced by a DNP marked mAb?
- 12/05/2019 - LO-HG4 Anti-human IgG4 monoclonal antibody
- 11/25/2019 - Hybridoma VS Display : The Fight Of The Century
- 11/14/2019 - Mycotoxins: the reign of terror
- 10/29/2019 - Smaltis & mAbexperts partnership
- 10/25/2019 - mAbexperts. What is it? How it works?
- 10/23/2019 - What is the Kd of your antibody?
- 10/18/2019 - Are you sure you know everything about the Rat?
- 10/02/2019 - The enigmatic subclass antibody, new SYngular products from SYnAbs
- 09/25/2019 - Three Letters You Should Be Aware Of
- 09/18/2019 - Answers to frequently asked questions on secondary antibodies
- 09/18/2019 - New logo for mAbexperts group
- 09/16/2019 - Your DNA isn't your destiny: news on epigenetics
- 08/07/2019 - SYnAbs enters in India!
- 07/02/2019 - mAbexperts commits to the future of immunotherapy: Complete VHH-CAR-T design
- 06/26/2019 - Best tips to select an outsourcing provider for custom antibody generation
- 06/25/2019 - SYnAbs attended Pivotal Scientific congress in Oxford
- 06/10/2019 - Innovative anti-VHH antibodies : SYnAbs enters the nano-world
- 06/08/2019 - Innovative tools to boost your research on infectious diseases
- 05/20/2019 - SYnAbs in United Kingdom for antibody generation
- 05/15/2019 - mAbexperts attends Buzz4Bio outsourcing congress
- 05/08/2019 - SYnAbs at Knowledge For Growth
- 04/29/2019 - SYnAbs attends K4G on May 9th
- 04/27/2019 - The CAM family: a new target for monitoring or treating cancers?
- 04/25/2019 - SYnAbs attends Biotechnica Labvolution congress
- 04/20/2019 - SYnAbs and Univercells announce service agreement on biosimilar
- 04/19/2019 - Meet mAb Experts at AIS Congress
- 04/16/2019 - Why DNA immunization is still necessary?
- 04/12/2019 - Replacing in-vivo by an in-vitro test? Rabies mAb example
- 03/23/2019 - SYnAbs recherche de nouveaux talents
- 03/11/2019 - Neurogenic and SYnAbs deal for schizophrenia detection
- 02/05/2019 - mAb Experts attends Buzz4Bio congress in France
- 01/28/2019 - Horiba & SYnAbs partnership : Production of guinea pig monoclonal antibody directed against a steroid hormone and its binding study thanks to SPRi technology
- 01/15/2019 - ZenTech and SYnAbs sign strategic partnership agreement to generate innovative monoclonal antibodies targeting 8 hemoglobinopathia diseases
- 11/28/2018 - SYnAbs: the launch of 3 innovative rat mAbs
- 11/14/2018 - SYnAbs is attending Medica congress
- 10/31/2018 - SYnAbs is at AusBiotech congress looking for Australian distributors
- 10/01/2018 - SYnAbs enters in Italy!
- 08/28/2018 - SYnAbs is proud to announce ISO 9001:2015 certification!
- 08/04/2018 - SYnAbs attended AACC congress in Chicago! Great success!
- 07/27/2018 - SYnAbs enters Chinese market!
- 06/25/2018 - SYnAbs is looking for new talents to expand its cell culture team
- 06/19/2018 - SYnAbs attended Pivotal Congress in Oxford
- 02/06/2018 - SYnAbs attended Buzz4Bio Cell&Gene Therapies
- 02/01/2018 - SYnAbs attended Innovation for Health in Rotterdam
- 01/24/2018 - SYnAbs launches mouse isotyping kit, MYstik™
- 01/24/2018 - SynAbs inks agreement with SKLM as new distributor for its unique catalogue of monoclonal antibodies in Morocco
- 01/17/2018 - SynAbs inks agreement with Theranostica as new distributor for its unique catalogue of monoclonal antibodies in Israël
- 12/14/2017 - SYnAbs/RD Biotech unique expertise in CAR-T cells
- 11/27/2017 - SynAbs, from UCL benches to Singapore
- 11/20/2017 - SynAbs attended Medica congress in Dusseldorf, Germany
- 10/24/2017 - SynAbs inks first distribution agreement in Asia
- 09/05/2017 - SynAbs widens its team to sustain organic growth
- 06/21/2017 - SynAbs attended Pivotal Scientific congress in Oxford!
- 06/01/2017 - SynAbs moves its facilities to Gosselies BioPark
- 05/24/2017 - SynAbs attended BioMed congress in Israël!
- 05/18/2017 - SynAbs attended Knowledge for Growth event in Ghent!
- 05/10/2017 - SynAbs attended WBC 10th anniversary as special guest!
- 05/05/2017 - SynAbs inks agreement with Sapphire as new distributor for its unique catalogue of monoclonal antibodies in USA & Canada
- 01/13/2017 - SynAbs inks agreement with Dianova GmbH as new distributor for its unique catalogue of monoclonal antibodies in Germany
- 09/19/2016 - SynAbs appoints LuBioScience GmbH as new distributor for its unique catalogue of monoclonal antibodies in Switzerland
- 08/03/2016 - Guinea pig monoclonal antibodies : a new promising tool for R&D, IVD and therapeutics
- 08/03/2016 - The small molecule detection challenge : the aflatoxin case study
- 01/28/2016 - SynAbs brings rats to antibody market
- 09/01/2015 - SynAbs set-up, a new rat mAb expert on the marketplace
